Page 229 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 229
Viral Hepatitis: Hepatitis B & D - Clinical (Therapy, New Compounds, Resistance)
P0632 BISPECIFIC ANTIBODY CONSTRUCTS MEDIATE SPECIFIC
RETARGETING TOWARDS AND ELIMINATION OF HBV-
POSITIVE HEPATOCYTES AND TUMOR CELLS
Felix Bohne*, Juia Hasreiter, Oliver Quitt, Jan-Hendrik Bockmann,
Frank Momburg, Ulrike Protzer, Germany
P0633 ASSOCIATION OF HEPATITIS B VIRUS GENETIC DIVERSITY
WITH TENOFOVIR DISOPROXIL FUMARATE RESPONSE
RATES IN IMMUNE TOLERANT CHRONIC HEPATITIS B
PATIENTS
James Lara, Hong Thai, Kathryn Kitrinos*, Guoliang Xia,
Anuj Gaggar, Matthew Paulson, Lilia Ganova-Raeva,Yury Khudyakov,
The United States
P0634 PEGINTERFERON IS SUPERIOR TO NUCLEOS(T)IDE
ANALOGS FOR PREVENTION OF HEPATOCELLULAR
CARCINOMA IN CHRONIC HEPATITIS B
Kung-Hao Liang, Chao-Wei Hsu, Ming-Ling Chang,Yi-Cheng Chen,
Ming-Wei Lai, Chau-Ting Yeh*, Taiwan
P0635 CHRONIC HEPATITIS B TREATMENT INDIVIDUALIZATION ePOSTERS
BY MEANS OF SERUM HBSAG AND MIR-B-INDEX
KINETICS
Daniela Cavallone*, Filippo Oliveri, Piero Colombatto, Barbara Coco,
Pietro Ciccorossi, Veronica Romagnoli, Beatrice Cherubini,
Francesco Moriconi, Bonino Ferruccio, Maurizia R. Brunetto, Italy
P0636 ANTIVIRAL EFFICACY AND INDUCTION OF HOST IMMUNE
RESPONSES WITH SB 9200, AN ORAL PRODRUG OF THE
DINUCLEOTIDE SB 9000, IN THE WOODCHUCK MODEL OF
CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
Kyle Korolowicz, Stefanie Czerwinski, Radhakrishnan Iyer, Jeffrey Skell,
Junming Yang, Robin Tucker, Stephan Menne*, The United States
P0637 SHORT-TERM ANTIVIRAL PROPHYLAXIS IS NOT
EFFECTIVE IN HBSAG-NEGATIVE, ANTI-HBC
POSITIVE, AND/OR ANTI-HBS PATIENTS UNDERGOING
HEMATOPOIETIC STEM CELL TRANSPLANTATION
Yoon Jun Kim*, Minjong Lee,Young Youn Cho, Jeong-Ju Yoo,Yuri Cho,
Dong Hyeon Lee, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu,
Jung-Hwan Yoon, Hyo-Suk Lee, South Korea
Vienna, Austria • April 22–26, 2015 229
P0632 BISPECIFIC ANTIBODY CONSTRUCTS MEDIATE SPECIFIC
RETARGETING TOWARDS AND ELIMINATION OF HBV-
POSITIVE HEPATOCYTES AND TUMOR CELLS
Felix Bohne*, Juia Hasreiter, Oliver Quitt, Jan-Hendrik Bockmann,
Frank Momburg, Ulrike Protzer, Germany
P0633 ASSOCIATION OF HEPATITIS B VIRUS GENETIC DIVERSITY
WITH TENOFOVIR DISOPROXIL FUMARATE RESPONSE
RATES IN IMMUNE TOLERANT CHRONIC HEPATITIS B
PATIENTS
James Lara, Hong Thai, Kathryn Kitrinos*, Guoliang Xia,
Anuj Gaggar, Matthew Paulson, Lilia Ganova-Raeva,Yury Khudyakov,
The United States
P0634 PEGINTERFERON IS SUPERIOR TO NUCLEOS(T)IDE
ANALOGS FOR PREVENTION OF HEPATOCELLULAR
CARCINOMA IN CHRONIC HEPATITIS B
Kung-Hao Liang, Chao-Wei Hsu, Ming-Ling Chang,Yi-Cheng Chen,
Ming-Wei Lai, Chau-Ting Yeh*, Taiwan
P0635 CHRONIC HEPATITIS B TREATMENT INDIVIDUALIZATION ePOSTERS
BY MEANS OF SERUM HBSAG AND MIR-B-INDEX
KINETICS
Daniela Cavallone*, Filippo Oliveri, Piero Colombatto, Barbara Coco,
Pietro Ciccorossi, Veronica Romagnoli, Beatrice Cherubini,
Francesco Moriconi, Bonino Ferruccio, Maurizia R. Brunetto, Italy
P0636 ANTIVIRAL EFFICACY AND INDUCTION OF HOST IMMUNE
RESPONSES WITH SB 9200, AN ORAL PRODRUG OF THE
DINUCLEOTIDE SB 9000, IN THE WOODCHUCK MODEL OF
CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
Kyle Korolowicz, Stefanie Czerwinski, Radhakrishnan Iyer, Jeffrey Skell,
Junming Yang, Robin Tucker, Stephan Menne*, The United States
P0637 SHORT-TERM ANTIVIRAL PROPHYLAXIS IS NOT
EFFECTIVE IN HBSAG-NEGATIVE, ANTI-HBC
POSITIVE, AND/OR ANTI-HBS PATIENTS UNDERGOING
HEMATOPOIETIC STEM CELL TRANSPLANTATION
Yoon Jun Kim*, Minjong Lee,Young Youn Cho, Jeong-Ju Yoo,Yuri Cho,
Dong Hyeon Lee, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu,
Jung-Hwan Yoon, Hyo-Suk Lee, South Korea
Vienna, Austria • April 22–26, 2015 229
